# A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas

> **NCT04390802** · — · UNKNOWN · sponsor: **Massachusetts General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Pituitary Adenoma

## Interventions

- **DRUG:** 5-aminolevulinic acid

## Key facts

- **NCT ID:** NCT04390802
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04390802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04390802, "A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04390802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*